Edition:
India

Julie Steenhuysen

Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources

21 Oct 2020

CHICAGO/WASHINGTON AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness in a study participant, four sources told Reuters.

EXCLUSIVE-U.S. trial of AstraZeneca COVID-19 vaccine may resume this week -sources

21 Oct 2020

CHICAGO/WASHINGTON, Oct 20 AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters.

EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources

20 Oct 2020

CHICAGO/WASHINGTON, Oct 20 AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters.

Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some

13 Oct 2020

CHICAGO Final data from Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday.

Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some

09 Oct 2020

CHICAGO Final data from Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday.

Exclusive: Moderna vaccine trial contractors fail to enroll enough minorities, prompting slowdown

06 Oct 2020

CHICAGO Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enroll enough Black, Latino and Native American participants to determine how well the vaccine works in these populations, company executives and vaccine researchers told Reuters.

Exclusive: Moderna vaccine trial contractors fail to enroll enough minorities, prompting slowdown - sources

06 Oct 2020

CHICAGO Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enroll enough Black, Latino and Native American participants to determine how well the vaccine works in these populations, company executives and vaccine researchers told Reuters.

Moderna COVID-19 vaccine appears safe, shows signs of working in older adults: study

30 Sep 2020

CHICAGO Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers said on Tuesday. | Video

U.S. vaccine program chief backs stricter rules for emergency use of COVID-19 shot

25 Sep 2020

CHICAGO The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant emergency use of new inoculations against the novel coronavirus.

World News